A New Era for Value-Based Care: Driving Better Outcomes Through Innovation and Patient-Centered Care November 7, 2024 Sponsored Content Views Driving Better Outcomes Through Innovation and Patient-Centered Care SPONSORED CONTENT In … Share this on: Read More »
November 5 is Finally Here: How the 2024 Elections Could Affect the 340B Program November 5, 2024 Shannon Young, Associate Editor/Senior Writer Views Voters will cast ballots in Tuesday's presidential contest between Vice President Kamala Harris (D) and former President Donald Trump (R). When voters across the U.S. cast their ballots in Tuesday’s elections, they will not just be deciding who will control [...] Please Login or Become a Paid Subscriber to View this Content If you are already a … Share this on: Read More »
Major GPO Sues HRSA over Restrictions on How 340B Hospitals Purchase Initial Drug Inventory November 5, 2024 William Newton, Associate Editor/Senior Writer Views Premier, a major GPO, has sued HRSA over a policy restricting how hospitals can purchase initial physical drug inventory. A major group purchasing organization (GPO) is suing the federal government over a policy that it claims unlawfully restricts how [...] Please Login or Become a Paid Subscriber to View this Content If you are already a … Share this on: Read More »
Lilly Backs Sanofi Lawsuit Seeking HRSA 340B Records, Argues Contract Pharmacy Agreements Violate 340B Statute November 5, 2024 William Newton, Associate Editor/Senior Writer Views Eli Lilly has filed an amicus brief in support of Sanofi's lawsuit seeking 340B contract pharmacy agreements from HRSA. Eli Lilly is backing Sanofi’s lawsuit to compel the federal government to release all 340B contract pharmacy agreements, arguing that [...] Please Login or Become a Paid Subscriber to View this Content If you are already a … Share this on: Read More »
BI Tightens Contract Pharmacy Restrictions for All Covered Entities November 5, 2024 William Newton, Associate Editor/Senior Writer Views Boehringer Ingelheim recently announced it will tighten its 340B contract pharmacy restrictions by requiring claims data submission. Drugmaker Boehringer Ingelheim (BI) will begin requiring all 340B covered entities to submit claims data to continue accessing 340B drugs [...] Please Login or Become a Paid Subscriber to View this Content If you are already a … Share this on: Read More »
Eli Lilly Announces Refunds for 340B Overcharges November 5, 2024 Bella Czajkowski, National Correspondent Views Eli Lilly announced that it will refund 340B covered entities that purchased certain medications following adjustments to their ceiling prices. Eli Lilly announced that it will refund 340B covered entities that purchased certain medications following adjustments to their ceiling prices. [...] Please Login or Become a Paid Subscriber to View this Content If you are already a … Share this on: Read More »